Neutrophil to lymphocyte ratio and risk of a first episode of stroke in patients with atrial fibrillation: a cohort study

J Thromb Haemost. 2015 Nov;13(11):1971-9. doi: 10.1111/jth.13006. Epub 2015 Sep 14.

Abstract

Background: The neutrophil to lymphocyte ratio (NLR) is associated with increased risk of cardiovascular morbidity and mortality. We aimed to assess the association between NLR and first episode of stroke in patients with atrial fibrillation.

Methods: Using the computerized database of the largest HMO in Israel, we identified a cohort of adults, aged 20 years or older, with atrial fibrillation diagnosed before 1 January 2012. Eligible subjects had no prior stroke or TIA, were not on anticoagulants at baseline, and had at least one blood cell count performed in 2011. The cohort (32,912 subjects) was followed for the first event of stroke or TIA until 31 December 2012.

Results: Overall 981 subjects developed stroke during a follow-up of 30,961 person-years (stroke rate, 3.17 per 100 person-years). The incidence rate of stroke increased across NLR quartiles: 2.27, 2.72, 3.26 and 4.54 per 100 person-years, respectively. Cox proportional hazard regression analysis adjusting for the individual CHA2 DS2 -VASc score risk factors showed that, compared with the lowest NLR quartile, the HR for stroke was 1.11 (95% CI, 0.91-1.35), 1.25 (1.03-1.51) and 1.56 (1.29-1.88) for the second, third and highest quartile, respectively. On stratified analysis, NLR refined the risk of stroke across all CHA2 DS2 -VASc score strata. Adding NLR to the CHA2 DS2 -VASc score increased the AUC from 0.627 (95% CI, 0.612-0.643) to 0.635 (0.619-0.651) (P = 0.037).

Conclusions: The neutrophil to lymphocyte ratio is directly associated with the risk of stroke in patients with atrial fibrillation. Future studies are needed to replicate these findings.

Keywords: atrial fibrillation; biomarker; clinical prediction rule; inflammation; stroke.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use
  • Area Under Curve
  • Atrial Fibrillation / blood*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy
  • Comorbidity
  • Databases, Factual
  • Female
  • Follow-Up Studies
  • Humans
  • Israel / epidemiology
  • Leukocyte Count
  • Logistic Models
  • Lymphocyte Count*
  • Male
  • Middle Aged
  • Neutrophils*
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk
  • Risk Assessment
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Stroke / epidemiology*
  • Stroke / etiology
  • Stroke / prevention & control
  • Young Adult

Substances

  • Anticoagulants